10x Genomics (TXG) Earnings Date, Estimates & Call Transcripts $8.59 +0.42 (+5.14%) Closing price 04:00 PM EasternExtended Trading$8.55 -0.04 (-0.47%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock 10x Genomics Earnings Summary 10x Genomics issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.36, which topped analysts' consensus estimates of -$0.45 by $0.09. Quarterly revenue fell 2.3% year-over-year to $154.88 million, above the consensus estimate of $131.91 million. With a trailing EPS of -$1.30, 10x Genomics' earnings are expected to grow next year, from ($1.43) to ($1.06) per share. Upcoming Q2 Earnings DateAug. 14After Market ClosesEstimatedConsensus EPS (May. 8) -$0.45 Actual EPS (May. 8) -$0.36 Beat By $0.09 Actual Revenue (May. 8) $154.88MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)TXG Upcoming Earnings10x Genomics' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules. Powered by Get 10x Genomics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 10x Genomics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTXG Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TXG Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. 10x Genomics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.54-$0.54-$0.54Q2 20251-$0.43-$0.43-$0.43$145.6 M$138.0 M - $142.0 MQ3 20252-$0.33-$0.32-$0.33Q4 20252-$0.32-$0.20-$0.26 FY 2025 6 -$1.62 -$1.49 -$1.56 Q1 20262-$0.35-$0.32-$0.34Q2 20262-$0.29-$0.23-$0.26Q3 20262-$0.29-$0.29-$0.29Q4 20261-$0.20-$0.20-$0.20 10x Genomics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/8/2025Q1 2025-$0.45-$0.36+$0.09-$0.28$131.91M$154.88M2/12/2025Q4 2024-$0.32-$0.40 -$0.08-$0.40--10/29/2024Q3 2024-$0.34-$0.30+$0.04-$0.30$158.84M$151.65M8/8/2024Q2 2024-$0.47-$0.32+$0.15-$0.32$150.90M$153.10M4/30/2024Q1 2024-$0.50-$0.50--$0.50$142.24M$141.01M2/15/2024Q4 2023-$0.36-$0.41 -$0.05-$0.41$182.73M$183.98M11/2/2023Q3 2023-$0.45-$0.51 -$0.06-$0.23$150.11M$153.64M8/3/2023Q2 2023-$0.39-$0.53 -$0.14-$0.53$139.97M$146.82M 10x Genomics Earnings - Frequently Asked Questions When is 10x Genomics's earnings date? 10x Genomics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on TXG's earnings history. What guidance has 10x Genomics issued on next quarter's earnings? 10x Genomics updated its second quarter 2025 earnings guidance on Thursday, May, 8th. The company issued revenue guidance of $138.0 million-$142.0 million, compared to the consensus revenue estimate of $145.6 million. Did 10x Genomics beat their earnings estimates last quarter? In the previous quarter, 10x Genomics (NASDAQ:TXG) reported ($0.36) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.09. Learn more on analysts' earnings estimate vs. TXG's actual earnings. How can I listen to 10x Genomics's earnings conference call? The conference call for 10x Genomics's latest earnings report can be listened to online. Listen to Conference Call How can I read 10x Genomics's conference call transcript? The conference call transcript for 10x Genomics's latest earnings report can be read online. Read Transcript How much revenue does 10x Genomics generate each year? 10x Genomics (NASDAQ:TXG) has a recorded annual revenue of $624.66 million. How much profit does 10x Genomics generate each year? 10x Genomics (NASDAQ:TXG) has a recorded net income of -$182.63 million. TXG has generated -$1.30 earnings per share over the last four quarters. What is 10x Genomics's EPS forecast for next year? 10x Genomics's earnings are expected to grow from ($1.43) per share to ($1.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies MIR Earnings Results ST Earnings Results CAMT Earnings Results TRNS Earnings Results ALNT Earnings Results EYPT Earnings Results LAB Earnings Results SENS Earnings Results CTKB Earnings Results AEHR Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBooz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong Earnings This page (NASDAQ:TXG) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TXG Stock Free TXG Stock Alerts